{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:07:18Z","timestamp":1789675638390,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jvir.2022.10.042","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T19:49:32Z","timestamp":1670615372000},"page":"694-701.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Survival and Toxicities after Yttrium-90 Transarterial Radioembolization of Cholangiocarcinoma in the RESiN Registry"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6869-8578","authenticated-orcid":false,"given":"Taylor J.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8082-0532","authenticated-orcid":false,"given":"Lea","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6885-0752","authenticated-orcid":false,"given":"Daniel Y.","family":"Sze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9761-2262","authenticated-orcid":false,"given":"Andrew S.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8185-7388","authenticated-orcid":false,"given":"Ripal T.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4191-4875","authenticated-orcid":false,"given":"Brian E.","family":"Kouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary S.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4569-2720","authenticated-orcid":false,"given":"Nima","family":"Kokabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9010-0563","authenticated-orcid":false,"given":"Christopher J.","family":"Grilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0533-2883","authenticated-orcid":false,"given":"Daniel B.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2022.10.042_bib1","first-page":"80","article-title":"Widening health disparities: increasing cholangiocarcinoma incidence in an underserved population","volume":"1","author":"Kumar","year":"2021","journal-title":"Gastro Hep Advances"},{"key":"10.1016\/j.jvir.2022.10.042_bib2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1200\/JCO.2022.40.4_suppl.378","article-title":"A\u00a0phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1","volume":"40","author":"Oh","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2022.10.042_bib3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1245\/s10434-007-9627-x","article-title":"Surgical management of intrahepatic cholangiocarcinoma--a population-based study","volume":"15","author":"Tan","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2022.10.042_bib4","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00259-011-1812-2","article-title":"EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds","volume":"38","author":"Giammarile","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2022.10.042_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","article-title":"Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.jvir.2022.10.042_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamaoncol.2019.3702","article-title":"Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial","volume":"6","author":"Edeline","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jvir.2022.10.042_bib7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jvir.2020.02.008","article-title":"Yttrium-90 radioembolization in intrahepatic cholangiocarcinoma: a multicenter retrospective analysis","volume":"31","author":"Buettner","year":"2020","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2022.10.042_bib8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jvir.2022.02.016","article-title":"Transarterial yttrium-90 radioembolization for unresectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"33","author":"Schartz","year":"2022","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2022.10.042_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00270-021-03002-0","volume":"45","author":"Garin","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2022.10.042_bib10","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.2147\/OTT.S202875","article-title":"A\u00a0pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma","volume":"12","author":"Zhen","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jvir.2022.10.042_bib11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00270-020-02569-4","article-title":"Yttrium-90 radioembolization in unresectable intrahepatic cholangiocarcinoma: results of a multicenter retrospective study","volume":"43","author":"Bargellini","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2022.10.042_bib12","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jvir.2019.06.003","article-title":"Radioembolization-induced chronic hepatotoxicity: a single-center cohort analysis","volume":"30","author":"Currie","year":"2019","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2022.10.042_bib13","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvir.2022.10.042_bib14","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evidence"},{"key":"10.1016\/j.jvir.2022.10.042_bib15","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.jvir.2021.08.009","article-title":"Neoadjuvant yttrium-90 transarterial radioembolization with resin microspheres prescribed using the Medical Internal Radiation Dose model for intrahepatic cholangiocarcinoma","volume":"32","author":"Sarwar","year":"2021","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2022.10.042_bib16","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1245\/s10434-020-08486-7","article-title":"Downstaging with radioembolization or chemotherapy for initially unresectable intrahepatic cholangiocarcinoma","volume":"27","author":"Riby","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2022.10.042_bib17","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1148\/radiol.2018171768","article-title":"Radiation segmentectomy: potential curative therapy for early hepatocellular carcinoma","volume":"287","author":"Lewandowski","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2022.10.042_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2022.10.042_bib19","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.18632\/oncotarget.28060","article-title":"Safety and initial efficacy of ablative radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma","volume":"12","author":"Paz-Fumagalli","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.jvir.2022.10.042_bib20","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.31557\/APJCP.2019.20.5.1497","article-title":"Frailty syndrome in biliary tract cancer patients: prevalence and associated factors","volume":"20","author":"Limpawattana","year":"2019","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044322013951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044322013951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:10:51Z","timestamp":1760940651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044322013951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1051044322013951"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2022.10.042","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival and Toxicities after Yttrium-90 Transarterial Radioembolization of Cholangiocarcinoma in the RESiN Registry","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2022.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2022","name":"copyright","label":"Copyright"}]}}